These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 23732149

  • 41. Renal denervation: transition from pathophysiology to clinical practice.
    Gossios TD, Ziakas A, Doumas M, Katsiki N, Petroglou D, Kouparanis A, Lillis L, Karvounis H.
    Angiology; 2014 Oct; 65(9):760-8. PubMed ID: 24402321
    [Abstract] [Full Text] [Related]

  • 42. Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias.
    Ukena C, Mahfoud F, Linz D, Böhm M, Neuberger HR.
    EuroIntervention; 2013 May; 9 Suppl R():R110-6. PubMed ID: 23732141
    [Abstract] [Full Text] [Related]

  • 43. Renal denervation: a novel non-pharmacological approach in heart failure.
    Böhm M, Ewen S, Linz D, Reil JC, Schirmer S, Ukena C, Mahfoud F.
    J Cardiovasc Transl Res; 2014 Apr; 7(3):330-7. PubMed ID: 24578253
    [Abstract] [Full Text] [Related]

  • 44. Percutaneous renal denervation: new treatment option for resistant hypertension and more?
    Ewen S, Ukena C, Böhm M, Mahfoud F.
    Heart; 2013 Aug; 99(15):1129-34. PubMed ID: 23418204
    [No Abstract] [Full Text] [Related]

  • 45. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 46. The Potential Role of Catheter-Based Renal Sympathetic Denervation in Chronic and End-Stage Kidney Disease.
    Sata Y, Schlaich MP.
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):344-52. PubMed ID: 26740184
    [Abstract] [Full Text] [Related]

  • 47. [Renal denervation in the treatment of hypertension].
    Tikkanen I, Lappalainen K.
    Duodecim; 2013 Jul; 129(8):825-32. PubMed ID: 23720950
    [Abstract] [Full Text] [Related]

  • 48. Renal denervation in hypertension: simplicity, or complexity?
    Lantelme P, Courand PY, Bricca G.
    Arch Cardiovasc Dis; 2014 Jul; 107(8-9):421-3. PubMed ID: 25128935
    [No Abstract] [Full Text] [Related]

  • 49. Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.
    Tam GM, Yan BP, Shetty SV, Lam YY.
    Int J Cardiol; 2013 Apr 15; 164(3):277-81. PubMed ID: 22336259
    [Abstract] [Full Text] [Related]

  • 50. [Catheter-based treatment of drug-resistant hypertension].
    De Benedetti E.
    Rev Med Suisse; 2011 Nov 16; 7(317):2242-4. PubMed ID: 22400353
    [Abstract] [Full Text] [Related]

  • 51. Pathophysiology I: the kidney and the sympathetic nervous system.
    de Jager RL, Blankestijn PJ.
    EuroIntervention; 2013 May 16; 9 Suppl R():R42-7. PubMed ID: 23732154
    [Abstract] [Full Text] [Related]

  • 52. Renal denervation: a potential new treatment modality for polycystic ovary syndrome?
    Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA.
    J Hypertens; 2011 May 16; 29(5):991-6. PubMed ID: 21358414
    [Abstract] [Full Text] [Related]

  • 53. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
    Bunte MC, Infante de Oliveira E, Shishehbor MH.
    JACC Cardiovasc Interv; 2013 Jan 16; 6(1):1-9. PubMed ID: 23266234
    [Abstract] [Full Text] [Related]

  • 54. Catheter-based arterial sympathectomy: hypertension and beyond.
    Prince EA, Murphy TP, Hampson CO.
    J Vasc Interv Radiol; 2012 Sep 16; 23(9):1125-34; quiz 1134. PubMed ID: 22920976
    [Abstract] [Full Text] [Related]

  • 55. Pathophysiology of resistant hypertension in chronic kidney disease.
    Campese VM.
    Semin Nephrol; 2014 Sep 16; 34(5):571-6. PubMed ID: 25416666
    [Abstract] [Full Text] [Related]

  • 56. Renal denervation for resistant hypertension treatment: a novel team approach.
    Fajadet J.
    EuroIntervention; 2012 Oct 16; 8(6):655-7. PubMed ID: 23086782
    [No Abstract] [Full Text] [Related]

  • 57. Second denervation in a patient with resistant hypertension.
    Prado JC, Salado D, Ruilope LM, Segura J.
    Clin Res Cardiol; 2016 Oct 16; 105(10):880-3. PubMed ID: 27278635
    [No Abstract] [Full Text] [Related]

  • 58. Effects of renal denervation on insulin resistance.
    Hering D, Esler MD, Schlaich MP.
    Expert Rev Cardiovasc Ther; 2012 Nov 16; 10(11):1381-6. PubMed ID: 23244359
    [Abstract] [Full Text] [Related]

  • 59. [Renal artery denervation for treating refractory hypertension].
    Benamer H, Louvard Y, Garot P, Unterseeh T, Hovasse T, Lefèvre T, Chevalier B, Morice MC.
    Ann Cardiol Angeiol (Paris); 2011 Dec 16; 60(6):354-60. PubMed ID: 22040858
    [Abstract] [Full Text] [Related]

  • 60. Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats.
    Maranon R, Lima R, Spradley FT, do Carmo JM, Zhang H, Smith AD, Bui E, Thomas RL, Moulana M, Hall JE, Granger JP, Reckelhoff JF.
    Am J Physiol Regul Integr Comp Physiol; 2015 Apr 15; 308(8):R708-13. PubMed ID: 25695289
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.